Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis

K Ghoreschi, A Balato, C Enerbäck, R Sabat - The Lancet, 2021 - thelancet.com
Psoriasis is a chronic inflammatory disease characterised by sharply demarcated
erythematous and scaly skin lesions accompanied by systemic manifestations. Classified by …

[HTML][HTML] Focus: skin: current developments in the immunology of psoriasis

F Grän, A Kerstan, E Serfling, M Goebeler… - The Yale journal of …, 2020 - ncbi.nlm.nih.gov
Psoriasis is a frequent inflammatory skin disease. Fundamental research on the
pathogenesis of psoriasis has substantially increased our understanding of skin …

Local IL-23 is required for proliferation and retention of skin-resident memory TH17 cells

SK Whitley, M Li, SW Kashem, T Hirai, BZ Igyártó… - Science …, 2022 - science.org
The cytokine interleukin-23 (IL-23) is critical for development and maintenance of
autoimmune inflammation in nonlymphoid tissues; however, the mechanism through which …

Divergent molecular networks program functionally distinct CD8+ skin-resident memory T cells

SL Park, SN Christo, AC Wells, LC Gandolfo, A Zaid… - Science, 2023 - science.org
Skin-resident CD8+ T cells include distinct interferon-γ–producing [tissue-resident memory T
type 1 (TRM1)] and interleukin-17 (IL-17)–producing (TRM17) subsets that differentially …

Efficacy and safety of biologics for psoriasis and psoriatic arthritis and their impact on comorbidities: a literature review

M Kamata, Y Tada - International journal of molecular sciences, 2020 - mdpi.com
Psoriasis is a chronic inflammatory skin disease characterized by scaly indurated erythema.
It impairs patients' quality of life enormously. It has been recognized not only as a skin …

Persistence of mature dendritic cells, TH2A, and Tc2 cells characterize clinically resolved atopic dermatitis under IL-4Rα blockade

C Bangert, K Rindler, T Krausgruber, N Alkon… - Science …, 2021 - science.org
Therapeutic options for autoimmune diseases typically consist of broad and targeted
immunosuppressive agents. However, sustained clinical benefit is rarely achieved, as the …

[HTML][HTML] Differential changes in inflammatory mononuclear phagocyte and T-cell profiles within psoriatic skin during treatment with guselkumab vs. secukinumab

H Mehta, S Mashiko, J Angsana, M Rubio… - Journal of Investigative …, 2021 - Elsevier
Cellular sources of IL-23 and IL-17A driving skin inflammation in psoriasis remain unclear.
Using high-dimensional unsupervised flow cytometry analysis, mononuclear phagocytes …

Pathophysiology of skin resident memory T cells

Y Tokura, P Phadungsaksawasdi, K Kurihara… - Frontiers in …, 2021 - frontiersin.org
Tissue resident memory T (TRM) cells reside in peripheral, non-lymphoid tissues such as
the skin, where they act as alarm-sensor cells or cytotoxic cells. Physiologically, skin TRM …

The biological basis of disease recurrence in psoriasis: a historical perspective and current models

L Puig, A Costanzo, EJ Muñoz‐Elías… - British Journal of …, 2022 - academic.oup.com
A key challenge in psoriasis therapy is the tendency for lesions to recur in previously
affected anatomical locations after treatment discontinuation following lesion resolution …

[HTML][HTML] The relapse of psoriasis: mechanisms and mysteries

D Tian, Y Lai - JID Innovations, 2022 - Elsevier
Over the past decades, tremendous success in the treatment of psoriasis has been achieved
using biologics, such as neutralizing antibodies against TNF/TNFR, IL-23, and IL-17A/IL …